Status:
COMPLETED
Dileucine and Resistance Training Adaptations
Lead Sponsor:
Lindenwood University
Collaborating Sponsors:
Ingenious Ingredients, L.P.
Conditions:
Hypertrophy
Strength Training Adaptations
Eligibility:
MALE
18-39 years
Phase:
NA
Brief Summary
This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provi...
Detailed Description
The study will be conducted using a randomized, double-blind approach with individuals being provided daily 2-gram doses of leucine, 2-gram doses of dileucine, or a placebo. Daily blinded supplementat...
Eligibility Criteria
Inclusion
- Male
- Between the ages of 18-39 years of age
- Currently participating in resistance training exercise
Exclusion
- Female
- Participants who are determined to not be weight stable defined as week 0 and week 2 body mass levels deviating by 3% or more.
- Any individual who is currently being treated for or diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, psychiatric, hematological, neurological or endocrinological disorder or disease.
- Body mass index \> 25 kg/m2. Individuals with a body mass index greater than 25 kg/m2, but a body fat percentage less than 25% fat will be accepted into the study
- Individuals who present with any previous injury or illness that would prevent them from appropriately completing all exercise lifts.
- Participants who are not able to fit onto the DEXA table will not be able to participate in the research due to size restrictions of the equipment. This typically includes individuals exceeding 400 pounds or those greater than 6'4".
- Those individuals with less than 12 months of structured resistance training experience will be excluded from the study.
- Individuals whose maximal relative upper body strength is below 1.0 will be excluded.
- Individuals whose maximal relative lower body strength is below 1.5 will be excluded.
- All participants who DO NOT abstain from taking any additional forms of nutritional supplementation deemed to be ergogenic or that will impact resistance training adaptations (pre-workouts, creatine, beta-alanine, etc.) for four weeks prior to beginning this study and for the entire duration of the study.
- Individuals who are currently using or have used within the past 12 months anabolic-androgenic steroids.
Key Trial Info
Start Date :
May 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06121869
Start Date
May 7 2021
End Date
June 29 2023
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Exercise and Performance Nutrition Laboratory
Saint Charles, Missouri, United States, 63301